Clinical Trial Update: Eltrombopag Olamine in Increasing Platelet Counts in Patients Undergoing Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating eltrombopag olamine for increasing platelet counts in patients undergoing bone marrow or cord blood hematopoietic cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Transplantation
• Cord Blood Transplantation
• Hematopoietic Cell Transplantation

Drugs mentioned

• Eltrombopag Olamine (eltrombopag olamine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Bone Marrow Transplantation Recipient, Cord Blood Transplant Recipient | Phase 2 | Status: COMPLETED | Results posted: 2024-04-23